Management of hypertension in the elderly population

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67, Issue 12, 2012, Pages 1343-1351

  Oliva, Raymond V ^a   Bakris, George L ^b  

^a PHILIPPINE GENERAL HOSPITAL   (Philippines)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Elderly adults; Hypertension; Management

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DIASTOLE; HUMAN; HYPERTENSION; LIFESTYLE; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CORONARY DISEASE; CREATININE; DIASTOLE; HUMANS; HYPERTENSION; LIFE STYLE;

EID: 84869475618     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls148     Document Type: Article

References (68)

1. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056-1065. (Pubitemid 47024610)
2. Weber M. A new mandate for treating hypertension in the elderly. Curr Hypertens Rep. 2008;10:258-260.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specifc relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913. (Pubitemid 35472129)
4. Burney BO, Bakris GL. Hypertension and its management in the elderly. Semin Nephrol. 2009;29:604-609.
5. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. (Pubitemid 351620109)
6. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123:2434-2506.
7. O'rourke MF. Mechanical principles. Arterial stiffness and wave refection. Pathol Biol (Paris). 1999;47:623-633.
8. Mackey RH, Sutton-Tyrrell K, Vaitkevicius PV, et al. Correlates of aortic stiffness in elderly individuals: a subgroup of the Cardiovascular Health Study. Am J Hypertens. 2002;15:16-23. (Pubitemid 34102267)
9. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456-1462. (Pubitemid 23296891)
10. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354-360. (Pubitemid 29362404)
11. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension. 1994;23:531-550. (Pubitemid 24102050)
12. Anderson DE, Parsons BA, McNeely JC, Miller ER. Salt sensitivity of blood pressure is accompanied by slow respiratory rate: results of a clinical feeding study. J Am Soc Hypertens. 2007;1:256-263. (Pubitemid 47091549)
13. Fliser D. Assessment of renal function in elderly patients. Curr Opin Nephrol Hypertens. 2008;17:604-608.
14. Fliser D, Ritz E. Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology. 1998;44:123-131. (Pubitemid 28185331)
15. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309-316. (Pubitemid 34260737)
16. Zhuo SQ, Yang XP, Chen YC, Tian XT, Lian H, Ou Q. Effect of obstructive sleep apnea syndrome on blood lipid and blood glucose in elderly hypertensive patients. Nan Fang yi Ke Da Xue Xue Bao. 2009;29:330-332.
17. Kohara K. [Clinical characteristic of secondary hypertension in the elderly]. Nihon Rinsho. 2005;63:1091-1095.
18. Casiglia E, Maschio O, Spolaore P, et al. Atrial fbrillation in a cohort of the elderly: etiopathogenic role of occult hyperthyroid-ism and diagnostic and therapeutic considerations. Results of the CASTEL (CArdiovascular STudy in the ELderly). Cardiologia. 1991;36:685-691.
19. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757-764. (Pubitemid 27387202)
20. Safar H, Chahwakilian A, Boudali Y, Debray-Meignan S, Safar M, Blacher J. Arterial stiffness, isolated systolic hypertension, and cardiovascular risk in the elderly. Am J Geriatr Cardiol. 2006;15:178-182.
21. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884-893. (Pubitemid 46768128)
22. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
23. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: fndings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol. 2002;13:2776-2782. (Pubitemid 35216048)
24. Davis EM, Appel LJ, Wang X, et al. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial. Hypertension. 2011;57:1061-1068.
25. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1986;293:1145-1151. (Pubitemid 16008923)
26. O'Malley K, McCormack P, O'Brien ET. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J Hypertens Suppl. 1988;6:S105-S108. (Pubitemid 19043908)
27. JATOS Study Group. The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the frst 12 months. Hypertens Res. 2005;28:513-520.
28. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839-846. (Pubitemid 28185548)
29. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888. (Pubitemid 35168144)
30. Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001;161:685-693. (Pubitemid 32200220)
31. Ogihara T. Antihypertensive treatment guideline for elderly hypertension. Nihon Rinsho. 2001;59:919-926.
32. Ruixing Y, Weixiong L, Hanjun Y, et al. Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Am J Hypertens. 2008;21:382-387. (Pubitemid 351450865)
33. Whelton PK, Babnson J, Appel LJ, et al. Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE). J Am Geriatr Soc. 1997;45:185-193. (Pubitemid 27066528)
34. Johnson AG. NSAIDs and blood pressure. Clinical importance for older patients. Drugs Aging. 1998;12:17-27. (Pubitemid 28033677)
35. Kean WF, Buchanan WW. The use of NSAIDs in rheumatic disorders 2005: a global perspective. Infammopharmacology. 2005;13:343-370. (Pubitemid 41617798)
36. Lund-Johansen P. Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlortha-lidone, polythiazide and hydrochlorothiazide. Acta Med Scand. 1970;187:509-518.
37. Dubois D, Gauchat M, Guelpa G. Arterial hypertension in the elderly. Is there still room for diuretics?. Praxis (Bern 1994). 1996;85:117-125. (Pubitemid 26051728)
38. Frishman WH. Comparative pharmacokinetic and clinical profles of angiotensin-converting enzyme inhibitors and calcium antagonists in systemic hypertension. Am J Cardiol. 1992;69:17C-25C.
39. Mariani L, Marino M, Cosentino N, Torrisi G. [Amlodipine in isolated systolic hypertension in the aged]. Clin Ter. 1993;143:35-43. (Pubitemid 23302287)
40. Clement DL, De BM, Duprez D. Antihypertensive effects of calcium antagonists. Clinical facts and modulating factors. Am J Hypertens. 1994;7:16S-22S. (Pubitemid 24248710)
41. Forette F, Bert P, Rigaud AS. Are calcium antagonists the best option in elderly hypertensives? J Hypertens Suppl. 1994;12:S19-S23. (Pubitemid 24283782)
42. Raspa RF, Wilson CC. Calcium channel blockers in the treatment of hypertension. Am Fam Physician. 1993;48:461-470. (Pubitemid 23268628)
43. Israili ZH, Hall WD. ACE inhibitors. Differential use in elderly patients with hypertension. Drugs Aging. 1995;7:355-371.
44. Pappoe LS, Winkelmayer WC. ACE inhibitor and angiotensin II type 1 receptor antagonist therapies in elderly patients with diabetes mel-litus: are they underutilized? Drugs Aging. 2010;27:87-94.
45. Mallion JM, Omboni S, Barton J, et al. Antihypertensive effcacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension. Blood Press. 2011;20(Suppl 1):3-11.
46. Cohn JN, Julius S, Neutel J, et al. Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial. Am J Hypertens. 2004;17:134-138. (Pubitemid 38125130)
47. Shinohara M, Washida N, Tanaka A, Ueda S, Kuwahara T, Kojima H. ACE inhibitor-induced acute renal failure in a patient with progressive systemic sclerosis: ischemic nephropathy mimicking PSS renal crisis. Intern Med. 2007;46:1605-1607. (Pubitemid 47521060)
48. Frazier JM, Kane KY. ACE inhibitors are better than diuretics for treatment of hypertension in the elderly. J Fam Pract. 2003;52:436-438. (Pubitemid 36706152)
49. Posvar EL, Sedman AJ. ACE inhibitors in the elderly. Angiology. 1991;42:387-396.
50. Lindholm LH, Ibsen H, Dahlof B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:1004-1010. (Pubitemid 34286537)
51. Kjeldsen SE, Jamerson KA, Bakris GL, et al. Predictors of blood pressure response to intensifed and fxed combination treatment of hypertension: the ACCOMPLISH study. Blood Press. 2008;17:7-17. (Pubitemid 351890487)
52. Moser M. Clinical experience with carvedilol. J Hum Hypertens. 1993;7(Suppl 1):S16-S20. (Pubitemid 23088737)
53. Lefferova K, Widimsky J, Lupinek Z. Beta-blockers in the treatment of hypertension in elderly patients. Vnitr Lek. 1991;37:128-134.
54. Moen MD, Wagstaff AJ. Nebivolol: a review of its use in the management of hypertension and chronic heart failure. Drugs. 2006;66:1389-1409.
55. Ladage D, Reidenbach C, Rieckeheer E, Graf C, Schwinger RH, Brixius K. Nebivolol lowers blood pressure and increases weight loss in patients with hypertension and diabetes in regard to age. J Cardiovasc Pharmacol. 2010;56:275-281.
56. Susic D, Varagic J, Ahn J, Matavelli L, Frohlich ED. Long-term min-eralocorticoid receptor blockade reduces fbrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am J Physiol Heart Circ Physiol. 2007;292:H175-H179. (Pubitemid 46105176)
57. Sander GE, Giles TD. Resistant hypertension: concepts and approach to management. Curr Hypertens Rep. 2011;13:347-355.
58. Inada M, Iwasaki K, Imai C, Hashimoto S. Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydroge-nase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity. Intern Med. 2008;47:2157-2164.
59. O'Malley K, McCormack P, O'Brien ET. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J Hypertens Suppl. 1988;6:S105-S108. (Pubitemid 19043908)
60. Coope JR, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. Br Med J (Clin Res Ed). 1987;294:179. (Pubitemid 17223875)
61. Perry HM Jr, Smith WM, McDonald RH, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989;20:4-13. (Pubitemid 19040206)
62. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264.
63. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
64. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ. 1992;304:405-412.
65. Casiglia E, Spolaore P, Mazza A, et al. Effect of two different therapeutic approaches on total and cardiovascular mortality in a Cardiovascular Study in the Elderly (CASTEL). Jpn Heart J. 1994;35:589-600. (Pubitemid 24356063)
66. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237-1245. (Pubitemid 26343504)
67. Wang JG, Staessen JA, Gong L, Liu L. Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med. 2000;160:211-220.
68. Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsar-tan in elderly isolated systolic hypertension study. Hypertension. 2010;56:196-202.